1. Home
  2. CMPO vs AORT Comparison

CMPO vs AORT Comparison

Compare CMPO & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompoSecure Inc.

CMPO

CompoSecure Inc.

HOLD

Current Price

$19.63

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$46.71

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPO
AORT
Founded
2000
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
CMPO
AORT
Price
$19.63
$46.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$25.50
$49.36
AVG Volume (30 Days)
1.1M
382.2K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,683,000.00
$422,646,000.00
Revenue This Year
$12.53
$15.97
Revenue Next Year
$9.95
$10.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.81
52 Week Low
$9.24
$21.97
52 Week High
$26.78
$48.25

Technical Indicators

Market Signals
Indicator
CMPO
AORT
Relative Strength Index (RSI) 47.21 57.96
Support Level $19.18 $42.68
Resistance Level $21.04 $48.25
Average True Range (ATR) 0.65 1.33
MACD -0.05 0.17
Stochastic Oscillator 24.19 72.35

Price Performance

Historical Comparison
CMPO
AORT

About CMPO CompoSecure Inc.

CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: